Dyslipidemia

Nietolerancja statyn: fakty i mity

Ulrich Laufs, Berend Isermann. Statin intolerance: myths and facts. Eur Heart J 2020 online (dostępny pełen tekst) Statin-associated muscle symptoms (SAMS) remain a highly controversial topic. Patients frequently complain about muscle symptoms that they associate with statin treatment while the… Czytaj więcej

Dyslipidemie – nowe wytyczne ESC

François Mach i wsp. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European Heart Czytaj więcej